ASS1 and neoplasm: Analysis of the extent of expression in the tumor stroma CAFs showed that no ASS1 expression occurred in the vast majority of tumors, thus 93/98 cases (negative 94.8%), while expression in 10–40% of the area of the stroma was noted in 5/98 (5.2%) cases (Table 1).